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Targeting of inflammatory cytokine networks by periodontal pathogens 
 
Background and Aim 
Periodontal diseases are a widespread group of destructive oral infection-driven 
inflammatory diseases that affect 50-80% of the general population worldwide (1). These 
pathologies include the reversible inflammation of the gingiva (gingivitis) and the irreversible 
chronic inflammatory destruction of the periodontal tissues (periodontitis), with eventual tooth 
loss. Even though periodontopathogenic bacteria in the form of biofilms are the primary 
etiologic factor of periodontitis, tissue destruction essentially results from the host immune 
response to the bacterial challenge (2). Among over 700 bacterial species living in the oral 
cavity, Porphyromonas gingivalis is considered a major component of the microbiota 
associated with severe forms of periodontitis (3). P. gingivalis produces a broad array of 
potential virulence factors, such as lipopolysaccharide (LPS), gingipains, and fimbriae, 
involved in tissue colonization and perturbation of the host defences. In this regard, 
considerable evidence has been accumulated demonstrating its ability to exploit complement 
receptors, cause chemokine “paralysis” or compete with other pathogens in eliciting 
inflammatory responses by the host (4, 5). Host defence against P. gingivalis requires 
coordination of multiple signalling pathways, which in turn initiate the production of pro-
inflammatory cytokines. Cytokines are secreted signalling molecules that play an important 
role in the innate immune responses to infection, and they are an integral part of the host 
inflammatory response in periodontal disease (6). The Interleukin (IL)-1 family (eleven 
members including IL-1β and IL-18) has a prominent role in these inflammatory responses by 
activation of other pro-inflammatory cytokines and recruitment of inflammatory cells to sites 
of infection (6). Their main cellular source is monocytes, cells that function at the front line of 
inflammatory responses against pathogens. Monocytes express several classes of pattern-
recognition receptors, such as nucleotide binding and oligomerization domain-like receptors 
(NLRs), which sense microbial molecules in the cytosol and thereafter activate IL-1β and IL-
18 secretion. NLRP3 is the best characterized member, which forms a multi-protein complex 
with the adaptor protein ASC and caspase-1 (7). This complex, namely “inflammasome” 
should be tightly regulated to control the potent proinflammatory activities of IL-1. In addition, 
monocytes express a recently identified receptor, namely triggering receptor expressed on 
myeloid cells-1 (TREM-1), whose activation can further amplify inflammatory responses to 
bacterial challenge, including IL-1 production (8). DAP12 is the intracellular adaptor molecule 
for TREM-1 that conveys the further downstream signalling that regulates inflammation (9). 
Further understanding of interactions between P. gingivalis and newly identified inflammatory 
signalling pathways should provide new insights into the pathogenesis of periodontal 
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diseases. The present thesis includes a series of in vitro studies aiming to investigate 
strategies by which P. gingivalis may collectively exploit the host inflammatory responses in 
monocytes. The complex interactions studied involved: a) antagonism with other pathogens 
for pro-inflammatory cytokine production, b) differential effects of P. gingivalis virulence 
factors on pro-inflammatory cytokine production, c) interference with the pathogen-sensing 
NLRP3 inflammasome, and d) amplification of pro-inflammatory cytokine production by the 
TREM-1/DAP12 pathway.  
 
Methods 
Human peripheral blood mononuclear cells (PBMC) were prepared by Ficoll density gradient 
sedimentation. For the enrichment of monocytes from PBMC, an antibody-mediated 
depletion technique was used. The purity of isolated monocytes was analyzed by CD14 
staining by flow cytometry. These isolated monocytes, or the monocytic cell line Monomac-6, 
were challenged with either live P. gingivalis W50 or its products (LPS and culture 
supernatants). To inhibit its cysteine proteinases (gingipains), bacterial supernatants were 
pretreated with the chemical inhibitor TLCK, or heated to 70 °C to inactivate protein content. 
The production of cytokines by the cells was measured by cytokine-specific enzyme-linked 
immunosorbent assay (ELISA). The expression of various genes was assessed by 
quantitative real-time RT-PCR. Confocal imaging was also used in order to investigate the 
concomitant presence of bacteria and protein expression at the intracellular level. 
Microbiological analysis was done by counting of total colony forming units.  
 
Results and discussion of the findings 
Two predominant periodontal pathogens, P. gingivalis and Campylobacter rectus were tested 
for their capacity to stimulate IL-1β, IL-6 and IL-8 production by human monoyctes 
(Publication I). Both species significantly stimulated the production of all three cytokines, but 
P. gingivalis had a considerably weaker effect. More strikingly, co-stimulation of the cells with 
P. gingivalis and C. rectus suppressed the cytokine-stimulatory capacity of the latter, rather 
than having a synergistic effect. Purified P. gingivalis LPS was alone sufficient to antagonise 
cytokine stimulation by C. rectus. This study highlighted the bi-phasic capacity of P. gingivalis 
to manipulate host inflammatory responses, either by inducing cytokine production, or by 
reducing the cytokine-stimulatory capacity of other pathogens. As the LPS appeared to have 
a predominant role in these effects, the potential differential effects of the two distinct LPS(s) 
of P. gingivalis were further investigated (Publication II). The newly identified A-LPS showed 
considerably weaker capacity to elicit IL-1 production by human monocytes, compared to the 
“classical” LPS. This is in line with previous reports showing that even small alterations in the 
 4 
LPS structure could alter the capacity of P. gingivalis to provoke host immune responses 
(10). Apart from its LPS, the gingipains of P. gingivalis constitute another set of virulence 
factors that can subvert the host immune responses. Inactivation of its gingipains caused a 
50% reduction in the capacity of P. gingivalis to stimulate IL-1β expression by monocytes, 
but it did not affect IL-18 gene expression. On the protein level though, the end-point effect 
on IL-1β secretion was attributed to the LPS, rather than the gingipains (Publication III). 
Hence, this study demonstrated that although IL-1β and IL-18 belong to the same cytokine 
family (11), the stimulation of their individual gene expression by P. gingivalis is attributed to 
different virulence factors. Moreover, the stimulation of gene expression and secretion of IL-
1β are regulated by distinct virulence factors of P. gingivalis. The regulation and processing 
of IL-1 cytokines was further considered on the intracellular level, by studying the regulation 
of the NLRP3 inflammasome complex in monocytes (Publication IV). Interestingly, the 
expression of the NLRP3 sensor was increased, whereas that of the ASC adaptor was 
decreased in response to P. gingivalis. These opposing actions of P. gingivalis may suggest 
a deregulation of the NLRP3 inflammasome complex, and hence an impairment of the 
capacity of the monocytes to sense pathogen signals, in order to efficiently process IL-1 
production. A further inflammatory pathway considered was the TREM-1/DAP12 pathway, 
which can amplify inflammatory events (Publication V). P. gingivalis enhanced TREM-1 gene 
expression and secretion in monocytes, whereas it had a bi-phasic effect on DAP12 
expression, well in line with the bi-phasic effects of P. gingivalis on the innate immune 
responses (12). Activation of TREM-1 in monocytes demonstrated a synergistic effect on the 
capacity of P. gingivalis to induce IL-1β and IL-6 secretion. Collectively, these data suggest 
that P. gingivalis may use the TREM-1/DAP12 pathway to enhance both local and systemic 
inflammation (13). 
 
Conclusion and significance 
Periodontal disease is the outcome of intricate inflammatory networks that are developed 
following a chronic cross talk between oral bacteria and the host cells in the periodontium. 
The present studies have revealed a complex interplay between P.gingivalis and monocytes. 
P. gingivalis may manipulate the host immune responses, inducing, amplifying or dampening 
pro-inflammatory cytokine production by the monocytes. This may provide an adaptational 
superiority to this species, by regulating the local defence mechanisms according to its 
occasional needs for survival and persistence in the host environment, thus contributing to 
the disease. A thorough understanding of such host inflammatory responses to P. gingivalis 
also allows for the exploration of new treatment strategies, aiming at their modulation. 
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